Halozyme Therapeutics | Stammkapital



Ordinary Share Capital Veränderung Datum
Acadia Pharmaceuticals USD 167.36M 167.35M 2025-06
Agios Pharmaceuticals USD 58.04M 57.96M 2025-06
Alnylam Pharmaceuticals USD 130.98M 129.67M 2025-06
Amarin USD 308.15M 2.85M 2025-03
Amgen USD 538M 33.04B 2025-06
Baxter International USD 683M 0 2024-12
Cytokinetics USD 119.6M 119.48M 2025-06
DBV Technologies USD 11.65M 1000 2025-03
Eli Lilly USD 946.83M 354.23M 2025-06
Halozyme Therapeutics USD 117.62M 117.5M 2025-06
Ionis Pharmaceuticals USD 159.2M 159.04M 2025-06
MannKind USD 306.33M 303.29M 2025-06
Pfizer USD 5.68B 5.2B 2025-06
United Therapeutics USD 45.22M 44.42M 2025-06


Halozyme Therapeutics Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.